Y H Shaib

Summary

Affiliation: Baylor College of Medicine
Country: USA

Publications

  1. ncbi Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study
    Yasser H Shaib
    Section of Health Services Research, Michael E DeBakey Veterans Affairs Medical Center, Baylor College of Medicine, Houston, Texas 77030, USA
    Gastroenterology 128:620-6. 2005
  2. ncbi The epidemiology of pancreatic cancer in the United States: changes below the surface
    Y H Shaib
    Section of Health Services Research, Michael E DeBakey Veterans Affairs Medical Center, Houston, TX 77030, USA
    Aliment Pharmacol Ther 24:87-94. 2006
  3. ncbi Endoscopic and surgical therapy for intrahepatic cholangiocarcinoma in the united states: a population-based study
    Yasser H Shaib
    Sections of Health Services, Houston, TX, USA
    J Clin Gastroenterol 41:911-7. 2007
  4. ncbi Incidence and survival of pancreatic head and body and tail cancers: a population-based study in the United States
    Melvin K Lau
    Sections of Gastroenterology and Health Services Research, Department of Veterans Affairs Medical Center, Houston, TX, USA
    Pancreas 39:458-62. 2010
  5. ncbi Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study
    Hashem B El-Serag
    Section of Health Services Research, Houston Veterans Affairs Medical Center, Baylor College of Medicine, 2002 Holcombe Boulevard 152, Houston, TX 77030, USA
    J Hepatol 44:158-66. 2006
  6. ncbi Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study
    Yasser H Shaib
    The Houston Veterans Affairs Medical Center and Baylor College of Medicine, Houston, Texas, USA
    Am J Gastroenterol 102:1016-21. 2007
  7. ncbi Utilization and determinants of adjuvant therapy among older patients who receive curative surgery for pancreatic cancer
    Jessica A Davila
    Sections of Health Services Research, The Houston Veterans Affairs Medical Center, Baylor College of Medicine, Houston, TX, USA
    Pancreas 38:e18-25. 2009
  8. ncbi Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?
    Yasser H Shaib
    The National Cancer Institute, NIH, Bethesda, MD, USA
    J Hepatol 40:472-7. 2004
  9. ncbi Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study
    Tania M Welzel
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USA
    Clin Gastroenterol Hepatol 5:1221-8. 2007

Detail Information

Publications9

  1. ncbi Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study
    Yasser H Shaib
    Section of Health Services Research, Michael E DeBakey Veterans Affairs Medical Center, Baylor College of Medicine, Houston, Texas 77030, USA
    Gastroenterology 128:620-6. 2005
    ..In this case-control study, we used the Surveillance, Epidemiology, and End Results-Medicare database to evaluate the prevalence of known risk factors for intrahepatic cholangiocarcinoma and explore other potential risk factors...
  2. ncbi The epidemiology of pancreatic cancer in the United States: changes below the surface
    Y H Shaib
    Section of Health Services Research, Michael E DeBakey Veterans Affairs Medical Center, Houston, TX 77030, USA
    Aliment Pharmacol Ther 24:87-94. 2006
    ..Pancreatic cancer is the fourth leading cause of cancer death in the United States...
  3. ncbi Endoscopic and surgical therapy for intrahepatic cholangiocarcinoma in the united states: a population-based study
    Yasser H Shaib
    Sections of Health Services, Houston, TX, USA
    J Clin Gastroenterol 41:911-7. 2007
    ..Intrahepatic cholangiocarcinoma (ICC) is a highly fatal disease with limited therapeutic options. The determinants, trends, and outcomes of different therapies for ICC are largely unknown in the United States...
  4. ncbi Incidence and survival of pancreatic head and body and tail cancers: a population-based study in the United States
    Melvin K Lau
    Sections of Gastroenterology and Health Services Research, Department of Veterans Affairs Medical Center, Houston, TX, USA
    Pancreas 39:458-62. 2010
    ..No studies have examined whether the demographics, disease characteristics, and patient survival with pancreatic body/tail cancers are different from pancreatic head tumors...
  5. ncbi Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study
    Hashem B El-Serag
    Section of Health Services Research, Houston Veterans Affairs Medical Center, Baylor College of Medicine, 2002 Holcombe Boulevard 152, Houston, TX 77030, USA
    J Hepatol 44:158-66. 2006
    ..Yet, neither the extent to which potentially curative or palliative therapy is used to treat HCC, nor the determinants of using such therapies are known. Further, it is unclear how effective different modalities are for treating HCC...
  6. ncbi Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study
    Yasser H Shaib
    The Houston Veterans Affairs Medical Center and Baylor College of Medicine, Houston, Texas, USA
    Am J Gastroenterol 102:1016-21. 2007
    ..We evaluated hepatitis C virus (HCV), hepatitis B virus (HBV), and liver cirrhosis as risk factors for intrahepatic cholangiocarcinoma (ICC) and extrahepatic cholangiocarcinoma (ECC)...
  7. ncbi Utilization and determinants of adjuvant therapy among older patients who receive curative surgery for pancreatic cancer
    Jessica A Davila
    Sections of Health Services Research, The Houston Veterans Affairs Medical Center, Baylor College of Medicine, Houston, TX, USA
    Pancreas 38:e18-25. 2009
    ..We conducted a population-based study to describe the utilization, determinants, and survival effects of adjuvant therapies after surgery among older patients with pancreatic cancer...
  8. ncbi Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?
    Yasser H Shaib
    The National Cancer Institute, NIH, Bethesda, MD, USA
    J Hepatol 40:472-7. 2004
    ..CONCLUSIONS: The incidence of ICC continues to rise in the USA. The stable proportions over time of patients with early stage disease, unstaged disease, tumor size <5 cm, and microscopic confirmation suggest a true increase of ICC...
  9. ncbi Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study
    Tania M Welzel
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USA
    Clin Gastroenterol Hepatol 5:1221-8. 2007
    ..Because the etiology of both tumors is poorly understood, a population-based case-control study was conducted to examine the association of ECC and ICC with preexisting medical conditions...